Ornidazole

Ornidazole 구조식 이미지
카스 번호:
16773-42-5
상품명:
Ornidazole
동의어(영문):
OPSS;1-Chloro-3-(2-Methyl-5-nitro-1H-iMidazol-1-yl)propan-2-ol;tiberal;alpha-(chlormethyl)-2-methyl-5-nitro-imidazol-1-aethanol;Ornidazol a-(ChloroMethyl)-2-Methyl-5-nitro-1H-iMidazole-1-ethanol;Madelen;Ornidal;ro7-0207;NSC 95075;Ornidazol
CBNumber:
CB5735895
분자식:
C7H10ClN3O3
포뮬러 무게:
219.63
MOL 파일:
16773-42-5.mol
MSDS 파일:
SDS

Ornidazole 속성

녹는점
85-90°C
끓는 점
443.2±40.0 °C(Predicted)
밀도
1.6545 (rough estimate)
굴절률
1.6000 (estimate)
저장 조건
Sealed in dry,Room Temperature
용해도
50mg/ml의 에탄올에 용해됨
산도 계수 (pKa)
2.4 ± 0.1(at 25℃)
색상
톨루엔의 결정
최대 파장(λmax)
276nm(H2SO4 aq.)(lit.)
Merck
14,6872
InChIKey
IPWKIXLWTCNBKN-UHFFFAOYSA-N
CAS 데이터베이스
16773-42-5(CAS DataBase Reference)
안전
  • 위험 및 안전 성명
  • 위험 및 사전주의 사항 (GHS)
위험품 표기 Xn
위험 카페고리 넘버 22
안전지침서 36
WGK 독일 3
RTECS 번호 NI5460000
HS 번호 2933.29.4300
위험 등급 IRRITANT
독성 LD50 in rats, mice (mg/kg): 1780, 1420 orally (Grunberg); LD50 in mice (mg/kg): >2000 orally, >2000 i.p. (Hoffer, Grunberg)
기존화학 물질 KE-05741
그림문자(GHS): GHS hazard pictograms
신호 어: Warning
유해·위험 문구:
암호 유해·위험 문구 위험 등급 범주 신호 어 그림 문자 P- 코드
H302 삼키면 유해함 급성 독성 물질 - 경구 구분 4 경고 GHS hazard pictograms P264, P270, P301+P312, P330, P501
예방조치문구:
P264 취급 후에는 손을 철저히 씻으시오.
P264 취급 후에는 손을 철저히 씻으시오.
P270 이 제품을 사용할 때에는 먹거나, 마시거나 흡연하지 마시오.
P330 입을 씻어내시오.
NFPA 704
0
2 0

Ornidazole MSDS


1(3-chloro-2-hydroxypropyl)-2-methyl-5-nitro imidazole

Ornidazole C화학적 특성, 용도, 생산

개요

Ornidazole is an orally bioavailable 5-nitroimidazole derivative with antibacterial and antiprotozoal activities. Ornidazole inhibits the growth of clinical isolates of B. fragilis (MICs = 0.5-5 μM) and various anaerobic bacteria when used at concentrations ranging from less than 0.1 to 3.2 μg/ml. It also inhibits the growth of Giardia isolates (IC50s = 0.01-0.47 μg/ml). Oral administration of ornidazole reduces T. vaginalis and T. foetus infection in mice and E. histolytica infection in rats with curative dose (CD50) values of 37, 3, and 10 mg/kg, respectively. Ornidazole (400 mg/kg per day) induces infertility in male rats within 7 days and inhibits spermatozoa binding to rat oocyte zona pellucida.

화학적 성질

Crystalline Solid

용도

Ornidazole is a drug that cures some protozoan infections. It has been investigated for use in Crohn's disease after bowel resection. It is indicated in treatment of mixed amoebiasis, mixed amoebic dysentery, mixed giardiasis, trichomoniasis, bacterial vaginosis, Sexually transmitted diseases, infections of gynaecology, lower respiratory tract infections, ENT, surgical and dental infections.

정의

ChEBI: A C-nitro compound that is 5-nitroimidazole in which the hydrogens at positions 1 and 2 are replaced by 3-chloro-2-hydroxypropyl and methyl groups, respectively. It is used in the treatment of susceptible protozoal infections and for the treatment of anaerobic bacterial infections.

Pharmaceutical Applications

A 5-nitroimidazole available for oral administration, intravenous infusion and as a vaginal pessary. Its activity closely parallels that of metronidazole and tinidazole.
Peak plasma levels after a single 750 mg or 1.5 g oral dose reach 11 mg/L and 30 mg/L, respectively, within about 2 h. The half-life is 12–14 h. It is well absorbed from the vagina, with peak plasma concentrations of 5 mg/L being reached 12 h after the insertion of a 500 mg vaginal pessary. After a single 1 g intravenous infusion for colorectal surgery, serum levels reached about 24 mg/L after 15 min and about 6 mg/L after 24 h. It has wide tissue distribution, including CSF. Plasma protein binding is 10–15%.
It is metabolized in the liver, mainly to hydroxymethyl derivatives. The plasma clearance rate decreases in hepatic failure because of reduced liver metabolism and decreased biliary elimination. About 60% of an oral dose is recovered in the urine and 20% in the feces. The dosing interval should be doubled in patients with severe hepatic impairment, but it is unnecessary to reduce the dose in patients with impaired renal function. It is removed by hemodialysis.
Toxicity and side effects are similar to those of metronidazole and tinidazole and it has similar clinical uses. It has been shown to be effective for the prevention of recurrence of Crohn’s disease after ileocolonic resection.

Safety Profile

Poison by intravenous route. Moderately toxic by ingestion and intraperitoneal routes. Experimental reproductive effects. Mutation data reported. Whenheated to decomposition it emits very toxic fumes of Clí and NOx.

Ornidazole 준비 용품 및 원자재

원자재

준비 용품


Ornidazole 공급 업체

글로벌( 539)공급 업체
공급자 전화 이메일 국가 제품 수 이점
Huadong Medicine (Xi'an)Bodyguard Pharmaceutical Co.,Ltd.
+86-029-86185165 +8618629664246
guoyuan@eastchinapharm.com China 1615 58
Hebei Lingding Biotechnology Co., Ltd.
+86-18031140164 +86-19933155420
erin@hbldbiotech.com China 878 58
Hebei Dangtong Import and export Co LTD
+8615632927689
admin@hbdangtong.com China 991 58
Henan Tengmao Chemical Technology Co. LTD
+8615238638457
salesvip2@hntmhg.com China 415 58
Shanghai Affida new material science and technology center
+undefined15081010295
2691956269@qq.com China 359 58
airuikechemical co., ltd.
+undefined86-15315557071
sales02@airuikechemical.com China 994 58
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512
info@tianfuchem.com China 21691 55
Shanxi Naipu Import and Export Co.,Ltd
+86-13734021967 +8613734021967
kaia@neputrading.com China 1011 58
Shanghai Zheyan Biotech Co., Ltd.
18017610038
zheyansh@163.com CHINA 3620 58
career henan chemical co
+86-0371-86658258
sales@coreychem.com China 29914 58

Ornidazole 관련 검색:

Copyright 2019 © ChemicalBook. All rights reserved